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PURPOSE: Foxhead boxM1 (FOXM1) expression has been shown to be linked with human papillomavirus (HPV) 16/
18–infected cervical cancer. However, the mechanism underlying the induction of FOXM1 in HPV 16/18–infected
cancers remains elusive. EXPERIMENTAL DESIGN: The mechanistic actions of FOXM1 induced by the E6/NKX2-1
axis in tumor aggressiveness were elucidated in cellular and animal models. The prognostic value of FOXM1 for
overall survival (OS) and relapse-free survival (RFS) in HPV-positive oral and lung cancerswas assessed using Kaplan-
Meier and Cox regression models. RESULTS: Herein, FOXM1 expression is upregulated by E6-mediated NKX2-1 in
HPV-positive cervical, oral, and lung cancer cells. Induction of FOXM1 by E6 through the MZF1/NKX2-1 axis is
responsible for HPV-mediated soft agar growth, invasiveness, and stemness through activating Wnt/β-catenin
signaling pathway. In a nude mice model, metastatic lung tumor nodules in HPV 18 E6-positive GNM or HPV 16 E6-
positive TL-1–injected nude mice were markedly decreased in both cell types with E6 knockdown, FOXM1
knockdown, or treatment with FOXM1 inhibitor (thiostrepton). Among the four subgroup patients, the worst FOXM1
prognostic value for OS and RFS was observed in HPV 16/18–positive patients with tumors with high-expressing
FOXM1.CONCLUSIONS: Induction of FOXM1 by E6 oncoprotein through theMZF1/NKX2-1 axismay be responsible
for HPV 16/18–mediated tumor progression and poor outcomes in HPV-positive patients.
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The high cancer risk of human papillomavirus (HPV) infection has
been recognized as being associated with genital-related cervical, vulvar,
and anal carcinomas [1,2] and non–genital-associated head and neck
squamous cell carcinomas (HNSCCs) [3,4]. However, the involvement
of HPV 16/18 infections in oral cavity squamous cell carcinoma
(OCSCC) and non–small cell lung cancer (NSCLC) remains
controversial [3–8]. The E6 and E7 proteins in high-risk HPV act as
primary transforming viral proteins to inactivate the p53 and Rb
pathways that result in cell proliferation and resistance to apoptosis [9].
This leads to the accumulation ofDNAdamage andmutations that give
rise to cell transformation and carcinoma development [9]. For
example, the positive correlation of HPV 16/18 infection with the risk
of epidermal growth factor receptor mutation occurrence has been
shown in Taiwanese NSCLC patients [10]. Further insights into the
mechanistic action of the E6 and E7 oncoproteins on tumor progression
should be investigated.
The overexpression of Foxhead boxM1 (FOXM1) is correlated with
tumor progression and poor prognosis in various human carcinomas,
including HNSCC [11,12] and NSCLC [13,14]. FOXM1 regulates
cell cycle–related gene expression, such as cyclin B1, cyclin D1, and
cdc25 expression, so as to promote cervical tumor progression [15].
However, the mechanism by which FOXM1 participates in HPV-
mediated tumor progression is not fully understood. FOXM1 is
upregulated by E2F1, which is released by Rb phosphorylation through
p53 inactivation [16,17]. FOXM1 interacts with HPV 16 E7 to
promote the transformation of primary rat embryo fibroblasts [18].
Here, we provide evidence that E7 does not affect FOXM1 expression
in HPV-positive cervical, oral, and lung cancer cells. Intriguingly,
FOXM1 expression is upregulated by E6 through E6-mediatedNKX2-
1 expression. Consequently, FOXM1 induced by the E6/NKX2-1 axis
is responsible for HPV-mediated tumor progression and metastasis
through increased β-catenin nuclear translocation.Materials and Methods
Study Subjects
OCSCC tumor specimens were collected from 110 patients with
primary oral cancers in the Department of Otolaryngology, Chung
Shan Medical University Hospital (Taichung, Taiwan) and the
Department of Surgical Pathology, Changhua Christian Hospital
(Changhua, Taiwan). Lung tumors were enrolled from 117 NSCLC
patients who were treated with surgical resection at the Division of
Thoracic Surgery, Taichung Veterans General Hospital (Taichung,
Taiwan) between 1993 and 2004. This study is approved by the
Institutional Review Board, Taipei Medical University Hospital
(TMUHNo. 201301051). The tumor type and stage of each collected
specimenwere histologically determined according to theWorldHealth
Organization classification system. Cancer relapse data were obtained
by chart review and further confirmed by two clinical physicians.
Immunohistochemistry
Formalin-fixed and paraffin-embedded specimens were sectioned
at a thickness of 3 μm. The detailed procedures were described
previously [10]. For antigen detection, sections were heated in a
microwave oven twice for 5 minutes in citrate buffer (pH 6.0) and
then incubated with a monoclonal anti–NKX2-1 (SC-53136; at a
dilution of 1:100) and FOXM1 antibody (GTX-100276; GeneTex,
Irvine, CA; at a dilution of 1:100) for 60 minutes at 25°C.Cell Lines and Culture Conditions
SiHa, C33A, H1299, and A549 cells were obtained from the
American Type Culture Collection (Manassas, VA). TheOECM-1 cells
were kindly provided byDr T. C. Lee (Institute of Biomedical Sciences,
Academia Sinica, Taipei, Taiwan). The GNM cells were kindly
provided by Dr M. Y. Chou (Department of Dentistry, Chung Shan
Medical University, Taichung, Taiwan). The TL-1 cells were
established from patients’ plural effusions as described previously [7].
The SiHa, GNM, H1299, and A549 cells were maintained in
Dulbecco’s modified Eagle’s medium. The TL-1, OECM, and C33A
cells were maintained in RPMI 1640 containing 10% FBS supple-
mented with penicillin (100 U/ml) and streptomycin (100 mg/ml).
Cells were grown in a 37°C humidified incubator with 5% CO2.
Western Blot Analysis
Cells were washed twice on ice with phosphate-buffered saline (PBS)
before adding protein lysis buffer [1× protease inhibitor cocktail (Roche,
Basel, Switzerland), 1.5mMEDTA, 1mMDTT, 10% glycerol, 25mM
Hepes, pH 7.6]. The protein concentration was determined by the
Bradford assay (BioRad, Hercules, CA) using BSA as a standard. Total
protein (20 μg) was resolved by 10% sodium dodecyl sulfate–
polyacrylamide gel electrophoresis (SDS-PAGE) for subsequent Western
blot analysis using antibodies against the following proteins [diluted in
Tween–Tris-buffered saline: 0.02% Tween-20 in 100 mM Tris-Cl (pH
7.5), 1:1000 as indicated]: monoclonal anti-p53 (DO7; Dako,
Carpinteria, CA), anti–HPV 16 E6 (sc-1586; Santa Cruz Biotechnology,
Dallas, TX), anti–HPV 18 E6 (sc-1584; Santa Cruz Biotechnology),
anti–HPV16E7 (sc-6981; Santa Cruz Biotechnology), anti–HPV18E7
(GTX40864; Gene Tex), anti-SP1 (sc-14027; Santa Cruz Biotechnol-
ogy), anti–α-tubulin (sc-5286; Santa Cruz Biotechnology), anti-Rb (sc-
102; Santa Cruz Biotechnology), anti–phosphorylated Rb (pRb; sc-
12901; Santa Cruz Biotechnology), anti–β-catenin (sc-7199; Santa Cruz
Biotechnology), anti–c-Myc (sc-40; Santa Cruz Biotechnology), anti-
vimentin (sc-6260; Santa Cruz Biotechnology), anti-Snail (sc28199;
Santa Cruz Biotechnology), anti-Nanog (sc-3769; Santa Cruz Biotech-
nology), anti-E2F1 (GTX11837; GeneTex), anti-Oct4 (100622;
GeneTex), anti-FOXM1 (GTX100276; GeneTex), anti–NKX2-1
(699P; Thermo Scientific, Pittsburgh, PA), anti–E-cadherin (80098;
BD Biosciences, San Jose, CA), and MMP2 (Lot 804P703C;
NeoMarkers, Woburn, MA). The gel was transferred to a Hybond-C
Extra membrane (GE Healthcare Life Science, Piscataway, NJ) and
immunoblotted with primary antibody, as indicated in the figure legends.
Anti-mouse or rabbit IgG conjugated to HRP was used as the secondary
antibody for detection using an ECL Western Blot Detection System.
Plasmid Construction
The NKX2-1 cDNAs were cloned into pcDNA3.1 Zeo(+)
(Invitrogen, Carlsbad, CA). The FOXM1-Luc and NKX2-1-Luc
plasmids were constructed by inserting KpnI/XhoI fragments into a
KpnI/XhoI-treated pGL3 vector (Promega Corp, Madison, WI). The
small hairpin NKX2-1 (shNKX2-1; TRCN0000275519), shMZF1
(TRCN0000017137), shLOX (TRCN0000045991), shFOXM1
(TRCN0000273982), shNEDD4 (TRCN0000004967), shβ-
catenin (TRCN0000314991), shCaveolin1 (TRCN0000007999),
and pLKO.1 vector plasmids were purchased from the National
RNAi Core Facility, Academia Sinica. HPV 16 E6 and HPV 18 E6
cDNAs and HPV 16 E6 and HPV 18 E6 shRNAs were as previously
described [19,20]. HPV 16 E7 and HPV 18 E7 shRNA template
were constructed using two complementary oligos that, when
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tarity to HPV 16 E7 and HPV 18 E7 mRNA. The oligos contained
19 to 20 nucleotides of the HPV 16 E7 and HPV 18 E7 sequence, as
follows: HPV 16 E7 shRNA forward, 5′-gatcaggaggatgaaata-
gatggtttcaagagaa TTTCAAGAGAA-3′; HPV 16 E7 shRNA reverse,
5′-agctaaaaaaggaggatgaaatagatggttctcttgaaa-3′; HPV 18 E7 shRNA
forward, 5′-gatcgtgttgtaagtgtgaagcc ttcaagagag-3′; HPV 18 E7
shRNA reverse, 5′-agctaaaaa -gtgttgtaagtgtgaagcctctcttgaag-3′.The
shRNA template was cloned into the pcDNA-HU6 vector as
previously described [21]. The various concentrations of expression
plasmids, as indicated, were transiently transfected into the lung
cancer cells (1 × 106) using the Turbofect reagent (Fermentas,
Pittsburgh, PA). After 48 hours, the cells were harvested, and the
whole-cell extracts were assayed in subsequent experiments.
Soft Agar Colony Formation Assay
For the soft agar colony formation assay, the bottom gel consisted
of 0.4% low-melting agarose (Cambrex, East Rutherford, NJ) in
RPMI 1640 containing 10% FBS. When the bottom layer of agarose
was solidified, 5 × 103 cells were resuspended in 2× RPMI 1640
containing 20% FBS, mixed with 0.6% agarose, and then plated
above this layer. Colonies larger than 100 μm in diameter were
quantified by microscope after 12 days of culture.
Invasion Assay
A Boyden chamber with a pore size of 8 μm was used for the
in vitro cell invasion assay. Cells (1 × 104) in 0.5% serum containing
culture medium (HyClone, Ogden, UT) were plated in the upper
chamber and 10% FBS was added to culture medium in the lower
chamber as a chemoattractant. The upper side of the filter was
covered with 0.2% Matrigel (Collaborative Research, Boston, MA)
diluted in RPMI 1640. After 12 hours, cells on the upper side of the
filter were removed and cells that adhered to the underside of the
membrane were fixed in methanol and stained with 10% Giemsa dye.
The number of invasive cells was counted. Ten contiguous fields of
each sample were examined to obtain a representative number of cells
that invaded across the membrane.Sphere Assay
Single cells were suspended in Matrigel/serum-free RPMI 1640
(1:1) at a concentration of 104 cells per well in a total volume of 100 μl,
in triplicate. Cells were further allowed to grow for 15 days, and the
number of spheres was counted by a microscope.
Xenograft Tumors in Nude Mice
Female immunodeficient nude mice (BALB/c nu/nu mice) that
were 5 weeks old and weighed 18 to 22 g were injected with PBS and
the stable clones of TL-1/NC, TL-1/shE6, TL-1/shE6+FOXM1, TL-
1/shFOXM1, GNM/NC, GNM/shE6, GNM/shE6+FOXM1, and
GNM/shFOXM1 through the tail vein (106 cells in 0.1 ml of PBS).
After 42 days, the mice were sacrificed, and their lungs were removed
and fixed in 10% formalin. The number of lung tumor metastasis was
counted under a dissecting microscope.
Statistical Analysis
The Student’s t test and Chi-square test were applied for
continuous or discrete data analysis. This analysis was performed
using SPSS software (version 13.0; SPSS Inc, Chicago, IL). For
survival data, statistical differences were analyzed using the log-ranktest. Survival curves were plotted using the Kaplan-Meier method,
and the variables related to survival were analyzed using Cox’s
proportional hazards regression model with SPSS software.Results
FOXM1 Expression Is Regulated by E6, Not by E7, in HPV-
Positive Cancer Cells
Western blot analysis showed that HPV 16 E6 and E7 were
expressed in HPV 16–positive SiHa cervical and TL-1 lung cancer
cells, as well as in HPV 18–positive GNM oral cancer cells (Figure 1A,
upper panel). As expected, HPV 16/18 E6 and E7 were not detected
in HPV 16/18–negative C33A cervical, H1299, A549 lung cancer,
and OECM-1 oral cancer cells. MMP2, a downstream gene of
FOXM1 expressed highly in HPV 16/18–positive SiHa, GNM, and
TL-1 cells, has a low level of expression in HPV 16/18–negative
C33A, A549, and OECM-1 cells (Figure 1A, upper panel). FOXM1
protein expression was consistent with its mRNA expression in these
cells (Figure 1A, lower panel). These results suggest that E6 or E7 may
contribute to increased FOXM1 expression at the transcription level.
To explore whether E6 or E7 could regulate FOXM1 expression, E6
or E7 shRNAs were transfected into HPV-positive SiHa, GNM, and
TL-1 cells. As expected, p53, Rb, and pRb were restored by E6 or E7
knockdown in these three cells when compared to parent cells
transfecting with non-specific shRNA control (NC; Figure 1B, upper
panel). Interestingly, FOXM1 expression was diminished by E6
knockdown to almost the degree seen in NC cells, but FOXM1
mRNA and protein expression were only slightly decreased by E7
knockdown in these three cell types (Figure 1B, upper and lower
panels). E2F1 expression was unchanged by E6 or E7 knockdown.
The interaction of E2F1 with Rb, when evaluated by immunopre-
cipitation, was expectedly increased by E6 or E7 knockdown and was
especially increased by E6 plus E7 knockdown (Figure 1B, middle
panel). These results suggest that FOXM1 expression may be
upregulated by E6 at the transcriptional level, not by E7, in HPV-
positive cancer cells.
FOXM1 Transcription Is Predominantly Upregulated by
E6-Mediated NKX2-1
Software analysis (http://alggen.lsi.upc.es/cgi-bin/promo_v3/promo/
promoinit.cgi?dirDB=TF_8.3) predicted that the three putative binding
sites for NKX2-1 (−1342/−923) were located upstream of the E2F1
binding sites on the FOXM1 promoter region (−1436/+1; Figure 2A,
upper panel). The possibility that NKX2-1 could play a more important
role than E2F1 in FOXM1 transcription was assessed by constructing
three FOXM1 promoters (P1: −1436/+1, P2: −766/+1, and P3: −
1436/−766; Figure 2A, lower panel). The luciferase reporter activity
assays showed that compared to P1, ~80% of the P3 promoter activity
was seen in E6-positive cells (TL-1, SiHa, and GNM), but this activity
was not observed in E6-negative cells (A549, C33A, and OECM-1;
Figure 2B). P3 promoter activity was significantly decreased by E6
knockdown in three E6-positive cell types (Figures 2, C andD, and 3E,
lower panel), but it was markedly increased by E6 overexpression in three
E6-negative cell types. Western blot analysis showed that NKX2-1
expression was reduced markedly in E6-knockdown SiHa, GNM, and
TL-1 cells but elevated in E6-overexpressing C33A, OECM-1, and
A549 cells (Figures 2, C and D, and 3E, upper panel). Chromatin
immunoprecipitation (ChIP) analysis indicated that NKX2-1 was
bound to its putative binding sites on the FOXM1 promoter in NKX2-
Figure 1. FOXM1 is upregulated by E6, not by E7, in HPV-infected cancer cells. (A) E6, E7, FOXM1, and MMP2 protein expressions were
evaluated by Western blot analysis in a panel of cancer cells with or without HPV infection. (B) E6 and E7 expressions were depleted by
shRNA in SiHa, GNM, and TL-1 cells. p53, E6, E7, E2F1, Rb, pRb, and FOXM1were detected by immunoblot analysiswith antibodies. These
lysates were immunoprecipitated with anti–Rb-conjugated beads. The immunoprecipitates were analyzed through SDS-PAGE, followed
by immunoblot analysis with anti-E2F1 antibody. Quantitative real-time PCR amplification of FOXM1 was performed using total cellular
RNA extracts. β-Actin was used as a loading control for the whole-cell lysates. Values are given as means ± SEMs for triplicate samples.
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in NKX2-1–knockdown C33A, OECM-1, and A549 cells transfected
with E6 (Figures 2, C and D, and 3E, middle panel). The binding
activity of NKX2-1 on the putative binding sites of the FOXM1
promoter was increased or decreased in the respective cell types in a dose-
dependent manner (Figures 2, C and D, and 3E, middle panel). These
results clearly indicate that E6-mediated NKX2-1 plays a more
important role than E2F1 does in the control of FOXM1 transcription
in HPV-positive cancer cells.
MZF1 Is Responsible for E6-Mediated NKX2-1 Expression
We next explored the mechanistic connection between E6 and
NKX2-1. We observed one NKX2-1, one SP1, one GATA-1,
and four MZF1 putative binding sites in the NKX2-1 promoter
region (−1000/+1) by a software analysis (Figure 3A). Three NKX2-
1 promoters (P1, P2, and P3) were constructed by deletion mutation
to test which transcription factor could be more responsible for
NKX2-1 transcription (Figure 3A). E6-positive SiHa, GNM, and
TL-1 cells were collected to transfect with shE6 and then co-
transfected with three NKX2-1 promoters for luciferase reporter
assay. As shown in Figure 3B, the reporter activity of the NKX2-1 P3
promoter was similar with the NKX2-1 P1 and P2 promoter
activities; however, the three promoter activities were almost reduced
by E6 knockdown in these three E6-positive cells. As shown in
Figure 3B, the reporter activity of these three NKX2-1 promoters did
not change by GATA-1 or SP1 silencing. We thus suggest that
GATA-1 and SP1 may play a minor role in NKX2-1 transcription.Therefore, GATA-1 or SP1 cannot increase NKX2-1 reporter
activity. These results suggest that the three MZF1 putative binding
sites located at the P3 promoter (−300/+1) may be responsible for
NKX2-1 transcription. Western blot showed that NKX2-1 and
MZF1 were concomitantly reduced by E6 knockdown in SiHa,
GNM, and TL-1 cells; however, NKX2-1 expression was restored by
MZF1 overexpression in E6-knockdown SiHa, GNM, and TL-1 cells
(Figure 3C, upper panel). ChIP analysis further indicated that MZF1
was indeed bound on the three MZF1 putative binding sites of the P3
promoter (−300/+1) but not observed in E6-knockdown cells
(Figure 3C, upper panel). The reporter activity of the P3 promoter
was consistent with the observations of Western blot analysis and
ChIP analysis (Figure 3C, lower panel). These results suggest that
MZF1 may be responsible for E6-mediated NKX2-1 expression in
HPV-positive cells.
Up-Regulation of FOXM1 by E6 through the MZF1/NKX2-1
Axis Is Responsible for HPV-Mediated Soft Agar Growth
and Invasion
We explored the possibility that the up-regulation of FOXM1 by
E6 through the MZF1/NKX2-1 could be responsible for HPV-
mediated soft agar growth and invasion capability. As expected,
FOXM1 expression was decreased by E6 knockdown in SiHa, GNM,
and TL-1 cells and increased by E6 overexpression in OECM-1,
C33A, and A549 cells (Figure 4, A–C, upper panel). In addition,
MMP2 and E-cadherin expressions were concomitantly increased
and decreased by E6-induced FOXM1 expression; however, both
Figure 2. Up-regulation of FOXM1 transcription by E6 is through increased NKX2-1 binding to the FOXM1 promoter. (A) Schematic
diagram of FOXM1 promoter–driven luciferase reporters: FOXM1 (−1436/+1)-Luc, FOXM1 (−766/+1)-Luc, and FOXM1 (−1436/-766)-
Luc. NKX2-1-A, NKX2-1-B, and NKX2-1-C possess putative NKX2-1 binding sites. (B) The three promoter constructs were co-transfected
into SiHa, C33A, GNM, OECM-1, TL-1, and A549 cells for luciferase reporter assay after 48 hours. Luciferase activity was measured at 48-
hour post-transfection. In all experiments, the relative luciferase activity was shown as the fold activation relative to that of the control
cells. (C) SiHa, GNM, and TL-1 cells were transfected with various doses of E6-knockdown plasmid as indicated. C33A, OECM-1, and
A549 cells were transfected with various doses of E6-overexpressing plasmid. The total amount of transfected DNAwas kept constant by
adding a control vector. The luciferase activity was measured at 48-hour post-transfection. In all experiments, the relative luciferase
activity was shown as the fold activation relative to that of the control cells. SiHa, GNM, and TL-1 cells were transfected with various
doses of E6-knockdown plasmid as indicated. C33A, OECM-1, and A549 cells were transfected with various doses of E6-overexpressing
plasmid. In addition, SiHa, GNM, and TL-1 cells were co-transfected with NKX2-1-overexpressing (5 μg) and E6-knockdown (5 μg)
plasmids. C33A, OECM-1, and A549 cells were co-transfected with shNKX2-1-knockdown (5 μg) and E6-overexpressing (5 μg) plasmids.
These lysates were immunoprecipitated with anti–NKX2-1-conjugated beads. The immunoprecipitates were analyzed through SDS-
PAGE, followed by immunoblot analysis with anti–NKX2-1 antibody. The input control was 30% of the cell extract without any treatment.
The binding activity of NKX2-1 onto the FOXM1 promoter was evaluated through chromatin immunoprecipitation. The chromatin was
isolated and immunoprecipitated with an antibody specific for NKX2-1.
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C33A, OECM-1, and A549 cells. The representative soft growth on
soft agar plate and invasive cell on Matrigel membrane are shown in
Figure 4, A to C (middle panel). The soft agar growth and invasion
capability were dose-dependently decreased and increased by E6
knockdown and E6 overexpression in these cells; however, both
capabilities were nearly restored by FOXM1 knockdown in E6-
overexpressing C33A, OECM1, and A549 cells (Figure 4, A–C,
lower panel). These results clearly indicate that up-regulation of
FOXM1 by E6 through the MZF1/NKX2-1 axis is responsible for
HPV-mediated soft agar growth and invasiveness.β-Catenin Activation Is Responsible for Invasiveness and
Stemness Caused by the E6-Induced FOXM1 through the
MZF1/NKX2-1 Axis
FOXM1 promotes β-catenin nuclear localization and controls Wnt
target gene expression, stemness, and glioma tumorigenesis [22–24].
Therefore, activation of the Wnt/β-catenin signaling pathway is
expected to be responsible for cell invasiveness and stemness mediated
by E6-induced FOXM1 expression. Western blot analysis showed
that nuclear β-catenin expression levels were elevated by ectopic
FOXM1 expression in E6-knockdown GNM cells; however, nuclear
β-catenin expression levels were reduced by FOXM1 silencing in E6-
Figure 3. MZF1 is responsible for E6-mediated NKX2-1 transcription. (A) Schematic representation of the 5′ flanking region of NKX2-1
promoter with putative NKX2-1, GATA-1, SP1, and MZF1 binding sites. +1, the transcription start site. The NKX2-1 (P1, −1000 to +1),
NKX2-1 (P2, −560 to +1), and NKX2-1 (P3, −300 to +1) luciferase reporter constructs. (B) The NKX2-1 (P1, −1000 to +1), NKX2-1 (P2,
−560 to +1), and NKX2-1 (P3, −300 to +1) luciferase reporter plasmids and shE6 (5 μg) plasmid were co-transfected into SiHa, GNM,
and TL-1 cells. (C) SiHa, GNM, and TL-1 cells were transfected with shE6 (5 μg) and MZF-1 (5 μg) cDNA plasmids as indicated. The
expression levels of E6, MZF1, and NKX2-1 were evaluated by Western blot analysis, and β-actin was served as protein loading control.
The binding activity of MZF-1 onto the NKX2-1 promoter was evaluated by ChIP in SiHa, GNM, and TL-1 cells that were transfected with
shE6 (5 μg) and MZF-1 (5 μg) cDNA plasmids as indicated. Chromatin was isolated and then immunoprecipitated with MZF-1–specific
antibody. The level of NKX2-1 (P3, −300 to +1) luciferase reporter plasmids was evaluated.
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catenin downstream gene—cyclin D1 and c-Myc—expressions were
consistent with nuclear β-catenin expression in both cell types
(Figure 5A, upper panel). The transcription factor 4 reporter activity
(TOPFlash) was significantly elevated by FOXM1 overexpression in
E6-knockdown GNM cells and reduced by FOXM1 knockdown in
E6-overexpressing OECM-1 cells. However, the transcription factor
4 reporter activity (FOPFlash) was unchanged in both cell types with
the same treatment (Figure 5A, lower panel). We examined whether
an increase in nuclear β-catenin expression by E6-mediated FOXM1could be responsible for cell invasiveness and stemness. As expected,
cyclin D1 and c-Myc expressions were decreased by β-catenin silencing
in E6-knockdown GNM cells with ectopic FOXM1 expression
(Figure 5B, upper panel). A Boyden chamber assay showed that the
invasiveness was markedly decreased by E6 knockdown; intriguingly,
the invasiveness was nearly restored by ectopic FOXM1 expression in
E6-knockdown GNM cells, as compared with VC cells (Figure 4B,
upper right panel). Moreover, the increase in invasiveness caused by
ectopic FOXM1 expression was rescued by β-catenin silencing in
E6-knockdown GNM cells with ectopic FOXM1 expression.
Figure 4. Induction of FOXM1 by E6 is responsible for colony formation and invasion capability. (A) E6 influenced FOXM1 expression in
lung cancer cells. Upper: E6 of SiHa was transiently knocked down by using various doses (2 and 5 μg) of E6 shRNA for this experiment.
The levels of the HPV 16 E6, p53, FOXM1, MMP2, E-cadherin, and β-actin proteins were evaluated throughWestern blot analysis. β-Actin
was used as a protein loading control. E6 expression changes resulting from using various doses (2 and 5 μg) of E6-overexpressing
plasmids were confirmed through Western blot analysis. In addition, C33A cells were co-transfected with shFOXM1-knockdown (5 μg)
and E6-overexpressing (5 μg) plasmids. The cell lysates were analyzed throughWestern blot analysis. The representative soft agar colony
sizes and invasion cell numbers are shown for cells. (B) GNM and OECM-1 cell lines. (C) TL-1 and A549 cell lines.
Neoplasia Vol. 16, No. 11, 2014 Chen et al. 967Interestingly, stemness-related c-Myc, Nanog, and Oct4 were elevated
by ectopic FOXM1 expression in E6-knockdown GNM cells
(Figure 5B, upper left panel). The representative invasiveness and sphere
cells are shown in Figure 4B (lower panel). E6-mediated cell invasiveness
due to increased FOXM1-mediated β-catenin nuclear translocation was
observed in the increase of sphere formation efficacy in GNM cells
(Figure 5B, upper right panel). Concomitantly, the Nanog, Oct4, and c-
Myc proteins and their mRNA expressions were dose-dependently
decreased by FOXM1 inhibitor (thiostrepton) in E6-overexpressing
OECM-1 cells (Figure 5C). Similar observations to those seen in GNM
oral cancer cells were also seen in TL-1 lung cancer cells (Figure S1).
These results clearly indicate that the increased nuclear translocation of
β-catenin due to E6-induced FOXM1 expression through the MZF1/
NKX2-1 axis is responsible for invasiveness and stemness in HPV-
positive oral and lung cancer cells.
E6-Induced FOXM1 Expression Is Responsible for HPV-
Mediated Xenograft Metastatic Lung Tumor Formation in
Nude Mice
We examined whether E6-induced FOXM1 expression could be
responsible for HPV-infected tumor progression in nude mice. Four
nude mice in each group were injected with E6-knockdown GNM or
TL-1, FOXM1-knockdown GNM or TL-1, or ectopic FOXM1
expression in E6-knockdown GNM or TL-1 stable clones. The
expression of E6 and FOXM1 in E6-knockdown, FOXM1-
knockdown, and E6/FOXM1-knockdown cells and the further
ectopic FOXM1 expression in E6-knockdown stable clones were
confirmed by Western blot analysis (Figure 6A, upper panel). The
change of FOXM1-mediated downstream genes Nanog, Oct4, and
c-Myc in GNM and TL-1 cells subjected to different treatments
was further evaluated by real-time polymerase chain reaction (PCR),indicating that these gene expression levels in both cells were
markedly decreased by E6 knockdown, FOXM1 knockdown, and
thiostrepton treatment. However, the decrease of these three gene
expressions by E6 knockdown in both cells was reversed by ectopic
FOXM1 expression. These results suggest that the expression of
Nanog, Oct4, and c-Myc elevated by E6-mediated FOXM1 may be
responsible for cell invasiveness and stemness in E6-positive oral and
lung cancer cells.
We next examined whether E6-mediated FOXM1 could
promote tumor progression and metastasis in nude mice. The
representative lung tumor nodules in the nude mice from each
group are shown in Figure 6 (upper panel), and these tumors were
confirmed by hematoxylin and eosin staining (Figure 6, middle
panel). The lung tumor nodules in nude mice injected with E6-
knockdown GNM or TL-1 stable clones decreased markedly
compared with those injected with their NC cells (Figure 6, lower
panel). The decrease in lung tumor nodules was observed in nude
mice injected with FOXM1-knockdown GNM or TL-1 stable
clones and in nude mice injected with NC cells treated with
FOXM1 inhibitor—thiostrepton. Intriguingly, the decrease in
lung tumor nodules was restored in nude mice injected with E6-
knockdown GNM or TL-1 stable clones with ectopic FOXM1
expression. These results clearly indicate that E6-induced FOXM1
expression is responsible for HPV-mediated xenograft metastatic
lung tumor formation.
HPV-Positive Patients with High-FOXM1 Tumors Exhibit the
Worst Overall Survival and Relapse-Free Survival among the
Four Subgroups
The data of HPV 16/18 DNA in OCSCC and NSCLC tumors
were collected from previous studies [5–7,10]. The presence of HPV
Figure 5. E6-induced FOXM1 expression promotes cell invasiveness and stemness through activating β-catenin/TCF signaling pathway in
OCSCC cells. (A) Western blot analysis of the total levels of E6, p53, FOXM1, cyclin D1, c-Myc, Nanog, Oct4, and β-catenin; cytoplasmic
and nuclear levels of β-catenin and FOXM1 in GNM and OECM-1 cells that were transfected with a vector (control, NC, or VC), FOXM1,
shFOXM1, E6, or shE6 plasmids, respectively. β-Actin, α-tubulin, and SP1 were used as the protein loading controls of whole-cell extracts,
as well as cytoplasmic and nuclear proteins. TOPFlash and FOPFlash activity levels were determined through luciferase reporter activity
assay. FOPFlash was used as a negative control. β-Gal served as an internal control. Values are given as means ± SEMs for triplicate
samples. (B) Western blot analysis of the total levels of E6, p53, FOXM1, cyclin D1, c-Myc, Nanog, Oct4, and β-catenin in GNM cells that
were, respectively, transfected with a vector (control, NC, or VC), shE6, FOXM1, and shβ-catenin plasmids. The sphere formation and
invasive cells were photographed (bottom) and quantified (upper right) The scale bar represents a length of 50 μm. (D) Western blot
analysis of the total levels of E6, p53, FOXM1, cyclin D1, c-Myc, Nanog, Oct4, and β-catenin in OECM-1–E6 cells on treatment with
thiostrepton at various dosages. Quantitative real-time PCR (right) was used to analyze the levels of FOXM1, Nanog, Oct4, and c-Myc
mRNA expression. The data shown are the means ± SDs of three independent experiments.
968 Chen et al. Neoplasia Vol. 16, No. 11, 2014DNA determined by nested PCR was further confirmed by in situ
hybridization or p16 immunostaining [5–7,10]. The immunohisto-
chemical data showed that FOXM1 expression was positively
correlated with NKX2-1 expression in oral and lung tumors (Tables 1
and S1). The positive association of HPV infection with FOXM1
expression was also observed in lung tumors (P b .001); however, this
association between HPV and FOXM1 was only marginally observed
in oral tumors; it did not reach statistical significance (P = .101). The
representative FOXM1 and NKX2-1 immunostaining results in serialparaffin sections of tumors are shown in Figure S2. A Cox regression
analysis showed that oral and lung cancer patients with high-FOXM1
tumors had shorter overall survival (OS) and shorter times to tumor
recurrence than oral and lung cancer patients with low-FOXM1
tumors (Table 2). In this study population, the prognostic value of
HPV infection for OS and relapse-free survival (RFS) was not
observed in oral and lung cancers, but the prognostic value of HPV
for RFS was seen in lung cancer patients. When oral and lung cancer
patients were divided into four subgroups using two parameters, HPV
Figure 6. E6-induced FOXM1 expression is responsible for HPV-mediated metastatic lung tumor formation in nude mice. An in vivo
metastasis assay was conducted by injecting nude mice with TL-1 (shGFP) and GNM (shGFP), a stable GNM (shE6) and TL-1 (shE6) clone
(1 × 106 cells per mouse), or PBS through the tail vein. The mice were sacrificed, and the lungs were excised on day 42. Representative
lungs bearing metastatic xenograft tumors were examined by hematoxylin and eosin staining, indicated with a “T”. The scale bar
represents a length of 100 μm (right). Data are presented as means ± SEMs; data were compared between groups using the t test, and
*P b .05 was considered to be statistically significant (the comparator was the control).
Table 1. Relationship of NKX2-1 and FOXM1 Expression with HPV 16/18 Infection in Patients with Cancer
Variables Oral Cancer (n = 110) Variables Lung Cancer (n = 117)
No. NKX2-1* FOXM1* No. NKX2-1* FOXM1 *
Low High P Low High P Low High P Low High P
HPV 16/18 infection HPV 16/18 infection
No 51 40 11 .003 33 18 .101 No 55 35 20 .007 34 21 b .001
Yes 59 30 29 29 30 Yes 62 24 38 12 50
NKX2-1 NKX2-1
Low 70 49 21 b .001 Low 59 29 30 .028
High 40 13 27 High 58 17 41
P value was obtained from Chi-square test.
* The expressions of NKX2-1 and FOXM1 were evaluated by immunohistochemistry as the text described.
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970 Chen et al. Neoplasia Vol. 16, No. 11, 2014and FOXM1, the highest hazard ratio (HR) value was observed in
HPV-positive oral and lung cancer patients with high-FOXM1
tumors (Table 2). These results suggest that the prognostic
significance of FOXM1 expression for OS and RFS was more
pronounced in HPV-positive oral and lung cancer patients.Discussion
In the present study, we provided the evidence to demonstrate that
FOXM1 upregulated by E6-mediated NKX2-1 was responsible for
tumor progression and metastasis in HPV-associated cervical, oral
cavity, and lung cancers. Importantly, a similar mechanistic action
shown in the three types of HPV-positive cancer cells appear to
support that FOXM1 may play a crucial role in HPV-associated
tumorigenesis. Moreover, the findings from the cell model were
further confirmed in xenograft tumors in nude mice. Therefore, we
suggest that FOXM1 might be potentially targeted to suppress tumor
progression and metastasis and, in turn, to improve outcomes in
patients with HPV 16/18 infection. The association of HPV infection
with cervical and oral cavity cancers has been documented [1–4];
however, the association between HPV infection and lung cancer is
still debated [25–27]. The involvement of HPV infection in
Taiwanese lung tumorigenesis has been extensively studied [5–7],
although the negative correlation between HPV infection and lung
cancer has been reported elsewhere [25–27]. Therefore, the
geographic variation has been considered to explain the difference
in the association between HPV infection and lung cancer.
The involvement of FOXM1 expression in HPV-associated
HNSCC and cervical tumor progression has been reported
[11–15]; however, the mechanistic action of FOXM1 expression in
HPV-associated tumor progression remains unclear. It is expected
that FOXM1 expression suppressed by wild-type p53 may be de-
repressed by E6-degraded p53. In the present study, we provide
evidence that E6-mediated MZF1/NKX2-1 axis plays a crucial role in
the up-regulation of FOXM1 transcription (Figures 2 and 3), which
is in contrast to previous reports that showed FOXM1 up-regulation
by E2F1 released by Rb phosphorylation through p53 inactivation
[16,17]. Up-regulation of FOXM1 by E6 through the MZF1/NKX2-
1 axis could explain why FOXM1 expression was higher in HPV-
positive cells than in HPV-negative cancer cells.
FOXM1 has been shown to promote tumor metastasis in human
hepatocellular carcinoma, glioma, and pancreatic cancer through
increased lysyl oxidase, NEDD4-1 and caveolin-1 expression [28,29].
However, we did not observe FOXM1-mediated lysyl oxidase,
NEDD4-1, and caveolin-1 being involved in the E6/MZF1/NKX2-
1/FOXM1 axis–mediated invasiveness in GNM and TL-1 cells
(Figure S3). Studies indicated that β-catenin was associated with
lymph node metastasis in cervical cancer [30] and the increased
expression of β-catenin indicated an increased risk of tumor local
recurrence compared to the low expression of β-catenin in HNSCC
[31]. Recently, nuclear β-catenin accumulation was associated with
increased Nanog expression and predicted poor prognoses in
NSCLC [32]. Therefore, β-catenin nuclear translocation has been
shown to be linked with tumor metastasis and stemness in cases of
cervical, HNSCC, and NSCLC. However, the molecular action of
β-catenin nuclear translocation in HPV-associated OCSCC and
NSCLC is still unclear. To the best of our knowledge, this is the first
time to demonstrate that E6-induced FOXM1 expression through
the MZF1/NKX2-1 axis promotes β-catenin nuclear translocation
Neoplasia Vol. 16, No. 11, 2014 Chen et al. 971and, in turn, enhances cell invasiveness and stemness in HPV-
positive OCSCC and NSCLC (Figures 4 and S1).
In summary, we provided evidence to demonstrate that the up-
regulation of FOXM1 through the E6/MZF1/NKX2-1 axis may be
responsible for HPV-infected tumor progression, poor survival, and
faster tumor recurrence in HPV-positive OCSCC and NSCLC
patients. Therefore, FOXM1 expression could feasibly predict
outcomes in HPV-positive OCSCC and NSCLC patients. We
suggest that the FOXM1 inhibitor thiostrepton might be useful
in suppressing tumor aggressiveness and consequently improving
outcomes in HPV-positive patients with tumors with high-
expressing FOXM1.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.neo.2014.09.010.
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